Cited by 167Cancer, Hypoxia, and MetabolismDiabetes Management and ResearchPancreatic function and diabetes

The DOI matches its Crossref record; 161 of the 163 references it cites were found in a registry or an index.

Hypoxia-inducible factors and diabetes

Open access

Gunton, Jenny E.·2020·Journal of Clinical Investigation

Open this paper in CoChat — free account Open PDF

Abstract

Hypoxia can be defined as a relative deficiency in the amount of oxygen reaching the tissues. Hypoxia-inducible factors (HIFs) are critical regulators of the mammalian response to hypoxia. In normal circumstances, HIF-1α protein turnover is rapid, and hyperglycemia further destabilizes the protein. In addition to their role in diabetes pathogenesis, HIFs are implicated in development of the microvascular and macrovascular complications of diabetes. Improving glucose control in people with diabetes increases HIF-1α protein and has wide-ranging benefits, some of which are at least partially mediated by HIF-1α. Nevertheless, most strategies to improve diabetes or its complications via regulation of HIF-1α have not currently proven to be clinically useful. The intersection of HIF biology with diabetes is a complex area in which many further questions remain, especially regarding the well-conducted studies clearly describing discrepant effects of different methods of increasing HIF-1α, even within the same tissues. This Review presents a brief overview of HIFs; discusses the range of evidence implicating HIFs in β cell dysfunction, diabetes pathogenesis, and diabetes complications; and examines the differing outcomes of HIF-targeting approaches in these conditions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci137556

Cites

161 of 162 references verified0 citation errors · 1 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726
A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Oxygen-induced retinopathy in the mouse.
Smith, L. E. H., Wesolowski, E., McLellan, A., Kostyk, S. K., D’Amato, R. J., Sullivan, R., & D'Amore, P. A. (1994) · PubMed · Cited by 1,627
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
Wang, G. L., & Semenza, G. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4304 · Cited by 1,468
The GLUT4 Glucose Transporter
Huang, S., & Czech, M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.03.006 · Cited by 1,450
FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
Mahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385
Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells.
Tian, H., McKnight, S. L., & Russell, D. W. (1997) · Genes & Development · doi:10.1101/gad.11.1.72 · Cited by 1,351
Activation of Hypoxia-inducible Transcription Factor Depends Primarily upon Redox-sensitive Stabilization of Its α Subunit
Huang, E. L., Arany, Z. P., Livingston, D. M., & Bunn, H. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32253 · Cited by 1,204
Chronic Hypoxia and Tubulointerstitial Injury
Nangaku, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005070757 · Cited by 1,146
Five stages of evolving beta-cell dysfunction during progression to diabetes
Weir, G. C., & Bonner-Weir, S. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s16 · Cited by 1,126
Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition
Higgins, D. F., Kimura, K., Bernhardt, W. M., Shrimanker, N., Akai, Y., Hohenstein, B., Saito, Y., Johnson, R. S., Kretzler, M., Cohen, C. D., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30487 · Cited by 976
Fibrosis and adipose tissue dysfunction.
Sun, K., Tordjman, J., Clément, K., & Scherer, P. E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.016 · Cited by 960
Biology of HIF-1α
Weidemann, A., & Johnson, R. S. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.12 · Cited by 941
Signaling pathways in insulin action: molecular targets of insulin resistance
Pessin, J. E., & Saltiel, A. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10582 · Cited by 939
Hypoxia-Inducible Factor 1α Induces Fibrosis and Insulin Resistance in White Adipose Tissue
Halberg, N., Khan, T., Trujillo, M. E., Wernstedt-Asterholm, I., Attie, A. D., Sherwani, S., Wang, Z. V., Landskroner-Eiger, S., Dineen, S., Magalang, U. J., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00192-09 · Cited by 896
Insulin-Dependent Diabetes Mellitus as an Autoimmune Disease
Bach, J. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-4-516 · Cited by 848
Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
Mazzone, M., Dettori, D., de Oliveira, R. L., Loges, S., Schmidt, T., Jonckx, B., Tian, Y.-M., Lanahan, A. A., Pollard, P. J., de Almodóvar, C. R., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.020 · Cited by 828
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Avery, R. L., Pearlman, J. A., Pieramici, D. J., Rabena, M., CASTELLARIN, A. A., Nasir, M. A., Giust, M. J., Wendel, R., & Patel, A. C. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.064 · Cited by 801
Desferrioxamine induces erythropoietin gene expression and hypoxia- inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction
Wang, G., & Semenza, G. (1993) · Blood · doi:10.1182/blood.v82.12.3610.3610 · Cited by 766
Obesity, insulin resistance and diabetes — a worldwide epidemic
Seidell, J. C. (2000) · British Journal Of Nutrition · doi:10.1017/s000711450000088x · Cited by 708
The changing face of diabetes complications
Gregg, E. W., Sattar, N. A., & Ali, M. K. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30010-9 · Cited by 659
Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
Kamura, T., Sato, S., Iwaï, K., Czyzyk-Krzeska, M., Conaway, R. C., & Conaway, J. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190332597 · Cited by 652
Cobalt Inhibits the Interaction between Hypoxia-inducible Factor-α and von Hippel-Lindau Protein by Direct Binding to Hypoxia-inducible Factor-α
Yuan, Y., Hilliard, G., Ferguson, T., & Millhorn, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300463200 · Cited by 638
The mammalian basic helix–loop–helix/PAS family of transcriptional regulators
Kewley, R. J., Whitelaw, M. L., & Chapman‐Smith, A. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00211-5 · Cited by 602
Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling
Rey, S., & Semenza, G. L. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq045 · Cited by 555
Stabilization of HIF-1α is critical to improve wound healing in diabetic mice
Botusan, I. R., Sunkari, V. G., Savu, O., Catrina, A. I., Grünler, J., Lindberg, S., Pereira, T., Ylä-Herttuala, S., Poellinger, L., Brismar, K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805230105 · Cited by 533
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
Ang, S. O., Chen, H., Hirota, K., Gordeuk, V. R., Jelinek, J., Guan, Y., Liu, E., Sergueeva, A. I., Miasnikova, G. Y., Mole, D., et al. (2002) · Nature Genetics · doi:10.1038/ng1019 · Cited by 510
Loss of ARNT/HIF1β Mediates Altered Gene Expression and Pancreatic-Islet Dysfunction in Human Type 2 Diabetes
Gunton, J. E., Kulkarni, R., Yim, S., Okada, T., Hawthorne, W. J., Tseng, Y., Roberson, R. S., Ricordi, C., O’Connell, P. J., Gonzalez, F. J., et al. (2005) · Cell · doi:10.1016/j.cell.2005.05.027 · Cited by 499
Self-citation
Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism
Aragonés, J., Schneider, M. A., Geyte, K. V., Fraisl, P., Dresselaers, T., Mazzone, M., Dirkx, R., Zacchigna, S., Lemieux, H., Jeoung, N. H., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.62 · Cited by 471
Insulin resistance and pancreatic cell failure
Kasuga, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29189 · Cited by 433
Pancreatic involvement in von Hippel–Lindau disease
Hammel, P. R., Vilgrain, V., Terris, B., Penfornis, A., Sauvanet, A., Corréas, J.-M., Chauveau, D., Balian, A., Beigelman‐Aubry, C., O’Toole, D., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.18143 · Cited by 425
The role of hypoxia-inducible factors in metabolic diseases
Gonzalez, F. J., Xie, C., & Jiang, C. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0096-z · Cited by 416
Mortality attributable to diabetes: Estimates for the year 2010
Roglić, G., & Unwin, N. C. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.006 · Cited by 400
Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia
Zhuang, Z., Yang, C., Lorenzo, F., Merino, M., Fojo, T., Kebebew, E., Popovic, V., Stratakis, C. A., Prchal, J. T., & Pacak, K. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205119 · Cited by 397
Hyperglycemia Regulates Hypoxia-Inducible Factor-1α Protein Stability and Function
Catrina, S., Okamoto, K., Pereira, T., Brismar, K., & Poellinger, L. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3226 · Cited by 392
The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2006) · Diabetes Care · doi:10.2337/dc06-0293 · Cited by 376
Thirty sweet years of GLUT4
Klip, A., McGraw, T. E., & James, D. E. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.008351 · Cited by 365
Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema
Arévalo, J. F., Fromow-Guerra, J., Quiroz–Mercado, H., Sánchez, J. G., Wu, L., Maia, M., Berrocal, M. H., Solis-Vivanco, A., & Farah, M. E. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.12.028 · Cited by 336
Resurgence of Diabetes-Related Nontraumatic Lower-Extremity Amputation in the Young and Middle-Aged Adult U.S. Population
Geiss, L. S., Li, Y., HORA, I. A., Albright, A. L., Rolka, D. B., & Gregg, E. W. (2018) · Diabetes Care · doi:10.2337/dc18-1380 · Cited by 333
A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis
Percy, M. J., Zhao, Q., Flores, A., Harrison, C., Lappin, T. R. J., Maxwell, P. H., McMullin, M. F., & Lee, F. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508423103 · Cited by 330
Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis
Takeda, Y., Costa, S., Delamarre, E., Roncal, C., de Oliveira, R. L., Squadrito, M. L., Finisguerra, V., Deschoemaeker, S., Bruyére, F., Wenes, M., et al. (2011) · Nature · doi:10.1038/nature10507 · Cited by 290
Inhibition of Hypoxia Inducible Factor Hydroxylases Protects Against Renal Ischemia-Reperfusion Injury
Hill, P., Shukla, D., Tran, M. G. B., Aragonés, J., Cook, H. T., Carmeliet, P., & Maxwell, P. H. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006090998 · Cited by 280
Autoimmune mechanisms in type 1 diabetes
Knip, M., & Siljander, H. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.04.008 · Cited by 279
Hypoxic induction of Ctgf is directly mediated by Hif-1
Higgins, D. F., Biju, M. P., Akai, Y., Wutz, A., Johnson, R. S., & Haase, V. H. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00245.2004 · Cited by 279
Disruption of Hypoxia-Inducible Factor 1 in Adipocytes Improves Insulin Sensitivity and Decreases Adiposity in High-Fat Diet–Fed Mice
Jiang, C., Qu, A., Matsubara, T., Chanturiya, T., Jou, W., Gavrilova, O., Shah, Y. M., & Gonzalez, F. J. (2011) · Diabetes · doi:10.2337/db11-0174 · Cited by 276
Stable expression of HIF-1α in tubular epithelial cells promotes interstitial fibrosis
Kimura, K., Iwano, M., Higgins, D. F., Yamaguchi, Y., Nakatani, K., Harada, K., Kubo, A., Akai, Y., Rankin, E. B., Neilson, E. G., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90209.2008 · Cited by 266
The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses
Bracken, C. P., Whitelaw, M. L., & Peet, D. J. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2370-y · Cited by 259
The Asparaginyl Hydroxylase Factor Inhibiting HIF-1α Is an Essential Regulator of Metabolism
Zhang, N., Fu, Z., Linke, S., Chicher, J., Gorman, J. J., Visk, D., Haddad, G. G., Poellinger, L., Peet, D. J., Powell, F. L., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.001 · Cited by 255
Ca2+/Calmodulin Kinase-dependent Activation of Hypoxia Inducible Factor 1 Transcriptional Activity in Cells Subjected to Intermittent Hypoxia
Yuan, G., Nanduri, J., Bhasker, C. R., Semenza, G. L., & Prabhakar, N. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407706200 · Cited by 253
Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules
Li, J., Liu, H., Takagi, S., Nitta, K., Kitada, M., Srivastava, S. P., Takagaki, Y., Kanasaki, K., & Koya, D. (2020) · JCI Insight · doi:10.1172/jci.insight.129034 · Cited by 246
Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates
Hewitson, K. S., Liénard, B. M. R., McDonough, M. A., Clifton, I. J., Butler, D., Soares, A. S., Oldham, N. J., McNeill, L. A., & Schofield, C. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608337200 · Cited by 235
Selective Inhibition of Hypoxia-Inducible Factor 1α Ameliorates Adipose Tissue Dysfunction
Sun, K., Halberg, N., Khan, M., Magalang, U. J., & Scherer, P. E. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00951-12 · Cited by 231
Hypoxia-inducible factor-1α regulates β cell function in mouse and human islets
Cheng, K., Ho, K., Stokes, R., Scott, C., Lau, S. M., Hawthorne, W. J., O’Connell, P. J., Loudovaris, T., Kay, T. W., Kulkarni, R. N., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci35846 · Cited by 230
Self-citation
Hypoxia-Inducible Factors 1α and 2α Regulate Trophoblast Differentiation
Dahl, K. D. C., Fryer, B. H., Mack, F. A., Compernolle, V., Maltepe, E., Adelman, D. M., Carmeliet, P., & Simon, M. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10479-10491.2005 · Cited by 229
Insulin resistance is a risk factor for progression to Type 1 diabetes
Fourlanos, S., Narendran, P., Byrnes, G. B., Colman, P. G., & Harrison, L. C. (2004) · Diabetologia · doi:10.1007/s00125-004-1507-3 · Cited by 228
Turning Signals On and Off: GLUT4 Traffic in the Insulin-Signaling Highway
Thong, F. S. L., Dugani, S. B., & Klip, A. (2005) · Physiology · doi:10.1152/physiol.00017.2005 · Cited by 227
Diabetes Mellitus: Incidence, Prevalence, Survivorship, and Causes of Death in Rochester, Minnesota, 1945–1970
Palumbo, P. J., Elveback, L. R., Chu, C.-P., Connolly, D. C., & Kurland, L. T. (1976) · Diabetes · doi:10.2337/diab.25.7.566 · Cited by 225
Renal diffusion and BOLD MRI in experimental diabetic nephropathy
Ries, M. G., Basseau, F., Tyndal, B., Jones, R., Deminière, C., Catargi, B., Combe, C., MOONEN, C. T. W., & Grenier, N. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10224 · Cited by 224
Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1α and VEGF
Poulaki, V., Qin, W., Joussen, A. M., Hurlbut, P., Wiegand, S. J., Rudge, J. S., Yancopoulos, G. D., & Adamis, A. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13776 · Cited by 222
Loss of Skeletal Muscle HIF-1α Results in Altered Exercise Endurance
Mason, S. D., Howlett, R. A., Kim, M. J., Olfert, I. M., Hogan, M. C., McNulty, W., Hickey, R. P., Wagner, P. D., Kahn, C. R., Giordano, F. J., et al. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020288 · Cited by 210
Cardiac myocyte‐specific HIF‐1α deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart
Huang, Y., Hickey, R. P., Yeh, J. L., Liu, D., Dadak, A. M., Young, L. H., Johnson, R. S., & Giordano, F. J. (2004) · The FASEB Journal · doi:10.1096/fj.04-1510fje · Cited by 209
The effect of altitude hypoxia on glucose homeostasis in men
Larsen, J. J., Hansen, J. M., Olsen, N. V., Galbo, H., & Dela, F. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.241bf.x · Cited by 206
HIF-1: the knowns and unknowns of hypoxia sensing.
Zagórska, A., & Dulak, J. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3545 · Cited by 194
Apoptosis in hypoxic human pancreatic islets correlates with HIF‐1α expression
Moritz, W., Meier, F., Stroka, D., Giuliani, M., Kugelmeier, P., Nett, P. C., Lehmann, R., Candinas, D., Gassmann, M., & Weber, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0403fje · Cited by 185
Activation of Hypoxia-Inducible Factors Prevents Diabetic Nephropathy
Nordquist, L., Friederich‐Persson, M., Fasching, A., Liss, P., Shoji, K., Nangaku, M., Hansell, P., & Palm, F. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013090990 · Cited by 185
Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury
Chang, Y., Choi, H., Jeong, J. Y., Na, K. R., Lee, K. W., Lim, B. J., & Choi, D. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158810 · Cited by 176
Regulation of hypoxia-inducible factor 1 and the loss of the cellular response to hypoxia in diabetes
Bento, C. F., & Pereira, P. (2011) · Diabetologia · doi:10.1007/s00125-011-2191-8 · Cited by 163
Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1
Marfella, R., D’Amico, M., Filippo, C. D., Piegari, E., Nappo, F., Esposito, K., Berrino, L., Rossi, F., & Giugliano, D. (2002) · Diabetologia · doi:10.1007/s00125-002-0882-x · Cited by 162
Skeletal Muscle Hypoxia-inducible Factor-1 and Exercise
Lindholm, M. E., & Rundqvist, H. (2016) · Experimental Physiology · doi:10.1113/ep085318 · Cited by 156
The subtle side to hypoxia inducible factor (HIFα) regulation
Bilton, R. L., & Booker, G. W. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03446.x · Cited by 150
Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes
Taniguchi, C. M., Finger, E. C., Krieg, A. J., Wu, C., Diep, A. N., LaGory, E. L., Wei, K., McGinnis, L. M., Yuan, J., Kuo, C. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3294 · Cited by 150
Hyperbaric oxygen therapy activates hypoxia‐inducible factor 1 ( HIF ‐1), which contributes to improved wound healing in diabetic mice
Sunkari, V. G., Lind, F., Botusan, I. R., Kashif, A., Liu, Z., Ylä‐Herttuala, S., Brismar, K., Velazquez, O. C., & Catrina, S. (2014) · Wound Repair and Regeneration · doi:10.1111/wrr.12253 · Cited by 137
HIF-1-driven skeletal muscle adaptations to chronic hypoxia: molecular insights into muscle physiology
Favier, F. B., Britto, F. A., Freyssenet, D. G., Bigard, X. A., & Benoit, H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2025-9 · Cited by 135
Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model
Ohtomo, S., Nangaku, M., Izuhara, Y., Takizawa, S., de Strihou, C. V. Y., & Miyata, T. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm715 · Cited by 132
Regulation of Gene Expression by HIF‐1
Semenza, G. L., Shimoda, L. A., & Prabhakar, N. R. (2006) · Novartis Foundation symposium · doi:10.1002/9780470035009.ch2 · Cited by 131
The adipocyte–myocyte axis in insulin resistance
Sell, H., Dietze‐Schroeder, D., & Eckel, J. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.10.010 · Cited by 131
Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes
Sartore, G., Chilelli, N. C., Burlina, S., & Lapolla, A. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0459-9 · Cited by 130
Intravitreous Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor 1a in Patients With Proliferative Diabetic Retinopathy
Wang, X., Wang, G., & Wang, Y. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.07.007 · Cited by 128
Deletion of the von Hippel–Lindau gene in pancreatic β cells impairs glucose homeostasis in mice
Cantley, J., Selman, C., Shukla, D., Abramov, A. Y., Forstreuter, F., Esteban, M. A., Claret, M., Lingard, S. J., Clements, M., Harten, S. K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci26934 · Cited by 127
Omental adipose tissue fibrosis and insulin resistance in severe obesity
Guglielmi, V., Cardellini, M., Cinti, F., Corgosinho, F. C., Cardolini, I., D’Adamo, M., Zingaretti, M. C., Bellia, A., Lauro, D., Gentileschi, P., et al. (2015) · Nutrition and Diabetes · doi:10.1038/nutd.2015.22 · Cited by 123
Cobalt induces hypoxia-inducible factor-1α (HIF-1α) in HeLa cells by an iron-independent, but ROS-, PI-3K- and MAPK-dependent mechanism
Triantafyllou, A., Liakos, P., Tsakalof, A. K., Georgatsou, E., Simos, G., & Bonanou, S. (2006) · Free Radical Research · doi:10.1080/10715760600730810 · Cited by 122
Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes
Sharma, S., Agrawal, R. P., Choudhary, M., Jain, S., Goyal, S., & Agarwal, V. (2011) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2011.03.003 · Cited by 120
Survival and causes of death in patients with von Hippel-Lindau disease
Binderup, M. L. M., Jensen, A. M., Budtz–Jørgensen, E., & Bisgaard, M. L. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104058 · Cited by 118
Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy
Sears, J. E., Hoppe, G., Ebrahem, Q., & Anand‐Apte, B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805817105 · Cited by 115
Oxygen Tension Regulates Pancreatic β-Cell Differentiation Through Hypoxia-Inducible Factor 1α
Heinis, M., Simon, M., Ilc, K., Mazure, N. M., Pouysségur, J., Scharfmann, R., & Duvillié, B. (2009) · Diabetes · doi:10.2337/db09-0891 · Cited by 112
Adipose Tissue-specific Inhibition of Hypoxia-inducible Factor 1α Induces Obesity and Glucose Intolerance by Impeding Energy Expenditure in Mice*
Zhang, X., Lam, K. S. L., Ye, H., Chung, S. K., Zhou, M., Wang, Y., & Xu, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.135509 · Cited by 112
Glucose-Induced O2 Consumption Activates Hypoxia Inducible Factors 1 and 2 in Rat Insulin-Secreting Pancreatic Beta-Cells
Bensellam, M., Duvillié, B., Rybachuk, G., Laybutt, D. R., Magnan, C., Guiot, Y., Pouysségur, J., & Jonas, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029807 · Cited by 109
Dynamic Production of Hypoxia-Inducible Factor-1α in Early Transplanted Islets
Miao, G., Ostrowski, R. P., Mace, J., Hough, J., Hopper, A. O., Peverini, R. L., Chinnock, R., Zhang, J. H., & Hathout, E. H. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01541.x · Cited by 104
pVHL is a regulator of glucose metabolism and insulin secretion in pancreatic β cellsPreprint
Zehetner, J., Danzer, C. F., Collins, S. C., Eckhardt, K., Gerber, P. A., Ballschmieter, P., Galvanovskis, J., Shimomura, K., Ashcroft, F. M., Thorens, B., et al. (2008) · Genes & Development · doi:10.1101/gad.496908 · Cited by 104
A liver Hif-2α–Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition
Wei, K., Piecewicz, S., McGinnis, L. M., Taniguchi, C. M., Wiegand, S. J., Anderson, K., Chan, C. W. M., Mulligan, K. X., Kuo, D. C., Yuan, J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3295 · Cited by 102
A Role for von Hippel-Lindau Protein in Pancreatic β-Cell Function
Puri, S., Cano, D. A., & Hebrok, M. (2008) · Diabetes · doi:10.2337/db08-0749 · Cited by 100
Loss of the First Phase Insulin Response to Intravenous Glucose in Subjects with Persistent Impaired Glucose Tolerance
Davies, M. J., Rayman, G., Grenfell, A., Gray, I. P., Day, J., & Hales, C. N. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00302.x · Cited by 94
Hypoxia-dependent activation of HIF into a transcriptional regulator
Ruas, J. L., & Poellinger, L. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.04.001 · Cited by 93
Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry
Percy, M. J., McMullin, M. F., Jowitt, S. N., Potter, M., Treacy, M., Watson, W. H., & Lappin, T. R. J. (2003) · Blood · doi:10.1182/blood-2002-10-3246 · Cited by 90
The Factor Inhibiting HIF Asparaginyl Hydroxylase Regulates Oxidative Metabolism and Accelerates Metabolic Adaptation to Hypoxia
Sim, J., Cowburn, A. S., Palazón, A., Madhu, B., Tyrakis, P. A., Macías, D., Bargiela, D., Pietsch, S., Gralla, M., Evans, C. E., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.020 · Cited by 89
Comparison of the Hydroxylase Inhibitor Dimethyloxalylglycine and the Iron Chelator Deferoxamine in Diabetic and Aged Wound Healing
Duscher, D., Januszyk, M., Maan, Z. N., Whittam, A. J., Hu, M. S.-M., Walmsley, G. G., Dong, Y., Khong, S. M. L., Longaker, M. T., & Gurtner, G. C. (2017) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000003072 · Cited by 86
Pathophysiological Consequences of HIF Activation
Haase, V. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05030.x · Cited by 85
Hypoxia reduces ER-to-Golgi protein trafficking and increases cell death by inhibiting the adaptive unfolded protein response in mouse beta cells
Bensellam, M., Maxwell, E. L., Chan, J. Y., Luzuriaga, J., West, P. K., Jonas, J., Gunton, J. E., & Laybutt, D. R. (2016) · Diabetologia · doi:10.1007/s00125-016-3947-y · Cited by 85
Self-citation
Fatty Acids Prevent Hypoxia-Inducible Factor-1α Signaling Through Decreased Succinate in Diabetes
Dodd, M. S., Fialho, M. D. L. S., Aparicio, C. N. M., Kerr, M. J., Timm, K. N., Griffin, J. L., Luiken, J. J. F. P., Glatz, J. F. C., Tyler, D. J., & Heather, L. C. (2018) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.04.005 · Cited by 81
Metabolic aspects of high‐altitude adaptation in Tibetans
Ge, R., Simonson, T. S., Gordeuk, V. R., Prchal, J. T., & McClain, D. A. (2015) · Experimental Physiology · doi:10.1113/ep085292 · Cited by 78
Hypoxia-Inducible Factor-1α (HIF-1α) Potentiates β-Cell Survival after Islet Transplantation of Human and Mouse Islets
Stokes, R., Cheng, K., Deters, N. A., Lau, S. M., Hawthorne, W. J., O’Connell, P. J., Stolp, J., Grey, S. T., Loudovaris, T., Kay, T. W. H., et al. (2012) · Cell Transplantation · doi:10.3727/096368912x647180 · Cited by 74
Self-citation
Asparagine and Aspartate Hydroxylation of the Cytoskeletal Ankyrin Family Is Catalyzed by Factor-inhibiting Hypoxia-inducible Factor
Yang, M. H., Ge, W., Chowdhury, R., Claridge, T. D. W., Kramer, H., Schmierer, B., McDonough, M. A., Gong, L., Kessler, B. M., Ratcliffe, P. J., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193540 · Cited by 73
Chromium Supplementation Does Not Improve Glucose Tolerance, Insulin Sensitivity, or Lipid Profile
Gunton, J. E., Cheung, N. W., Hitchman, R., Hams, G., O’Sullivan, C., Foster‐Powell, K., & McElduff, A. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.712 · Cited by 73
Self-citation
Impact of the Hypoxia-Inducible Factor-1 α (HIF1A) Pro582Ser Polymorphism on Diabetes Nephropathy
Gu, H., Zheng, X., Seman, N. A., Gu, T., Botusan, I., Sunkari, V., Lokman, E. F., Brismar, K., & Catrina, S. (2013) · Diabetes Care · doi:10.2337/dc12-1125 · Cited by 72
Pancreatic lesions in von Hippel–Lindau disease
Mukhopadhyay, B., Sahdev, A., Monson, J. P., BESSER, G. M., Reznek, R. H., & Chew, S. L. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01637.x · Cited by 70
A common haplotype and the Pro582Ser polymorphism of the hypoxia-inducible factor-1α (HIF1A) gene in elite endurance athletes
Döring, F., Onur, S., Fischer, A., Boulay, M. R., Përusse, L., Rankinen, T., Rauramaa, R., Wolfarth, B., & Bouchard, C. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01165.2009 · Cited by 67
HIF2AMutations in Paraganglioma with Polycythemia
Favier, J., Buffet, A., & Gimenez‐Roqueplo, A. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1211953 · Cited by 65
Loss of HIF-1α impairs GLUT4 translocation and glucose uptake by the skeletal muscle cells
Sakagami, H., Makino, Y., Mizumoto, K., Isoe, T., Takeda, Y., Watanabe, J., Fujita, Y., Takiyama, Y., Abiko, A., & Haneda, M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00597.2012 · Cited by 65
Cardiac-Specific Overexpression of HIF-1α Prevents Deterioration of Glycolytic Pathway and Cardiac Remodeling in Streptozotocin-Induced Diabetic Mice
Xue, W., Cai, L., Tan, Y., Thistlethwaite, P. A., Kang, Y. J., Li, X., & Feng, W. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091091 · Cited by 60
Hypoxia-inducible factor 1α protects peripheral sensory neurons from diabetic peripheral neuropathy by suppressing accumulation of reactive oxygen species.
Rojas, D. R., Tegeder, I., Kuner, R., & Agarwal, N. K. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1707-9 · Cited by 56
The associations of objectively measured sleep duration and sleep disturbances with diabetic retinopathy
Chew, M., Tan, N. Y. Q., Lamoureux, E. L., Cheng, C., Wong, T. Y., & Sabanayagam, C. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107967 · Cited by 53
Chromium Effects on Glucose Tolerance and Insulin Sensitivity in Persons at Risk for Diabetes Mellitus
Ali, N. D. A., Ma, Y., Reynolds, J., Wise, J. P., Inzucchi, S. E., & Katz, D. L. (2010) · Endocrine Practice · doi:10.4158/ep10131.or · Cited by 52
HIF2 α Is an Essential Molecular Brake for Postprandial Hepatic Glucagon Response Independent of Insulin Signaling
Ramakrishnan, S. K., Zhang, H., Takahashi, S., Centofanti, B., Periyasamy, S., Weisz, K. M., Chen, Z., Uhler, M. D., Rui, L., Gonzalez, F. J., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.004 · Cited by 50
Decreased serum glucose and glycosylated hemoglobin levels in patients with Chuvash polycythemia: a role for HIF in glucose metabolism
McClain, D. A., Abuelgasim, K. A., Nouraie, M. S., Salomón-Andonie, J., Niu, X., Miasnikova, G., Polyakova, L. A., Sergueeva, A., Okhotin, D. J., Cherqaoui, R., et al. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0961-5 · Cited by 49
Hypoxia in Combination With Muscle Contraction Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle via the HIF-1α Pathway
Görgens, S. W., Benninghoff, T., Eckardt, K., Springer, C. A., Chadt, A., Melior, A., Wefers, J., Cramer, A., Jensen, J., Birkeland, K. I., et al. (2017) · Diabetes · doi:10.2337/db16-1488 · Cited by 47
The Melbourne Pre‐Diabetes Study: prediction of type 1 diabetes mellitus using antibody and metabolic testing
Colman, P. G., McNair, P. D., Margetts, H., Schmidli, R. S., Tait, B. D., Honeyman, M. C., Harrison, L. C., Werther, G. A., ALFORD, F. P., & Ward, G. M. (1998) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1998.tb140188.x · Cited by 46
Transient expression of hypoxia-inducible factor-1 alpha and target genes in peripheral nerves from diabetic rats
Chavez, J. C., Almhanna, K., & Berti‐Mattera, L. N. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.050 · Cited by 46
Fasting plasma glucose variability levels and risk of adverse outcomes among patients with type 2 diabetes: A systematic review and meta-analysis
Zhao, Q., Zhou, F., Zhang, Y., Zhou, X., & Ying, C. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.12.010 · Cited by 43
First Phase Insulin Secretion and Type 2 Diabetes
Cheng, K., Andrikopoulos, S., & Gunton, J. E. (2012) · Current Molecular Medicine · doi:10.2174/1566524011307010126 · Cited by 42
Self-citation
Cardiac-specific ablation of ARNT leads to lipotoxicity and cardiomyopathy
Wu, R., Chang, H., Khechaduri, A., Chawla, K., Tran, M., Chai, X., Wagg, C. S., Ghanefar, M., Jiang, X., Bayeva, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76737 · Cited by 41
Serum chromium does not predict glucose tolerance in late pregnancy
Gunton, J. E., Hams, G., Hitchman, R., & McElduff, A. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.1.99 · Cited by 41
Self-citation
Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice
Thomas, A., Belaidi, E., Aron-Wisnewsky, J., van der Zon, G. C., Levy, P., Clement, K., Pepin, J.-L., Godin-Ribuot, D., & Guigas, B. (2016) · Scientific Reports · doi:10.1038/srep24618 · Cited by 33
First Phase Insulin Secretion and Type 2 Diabetes
Cheng, K., Andrikopoulos, S., & Gunton, J. E. (2012) · Current Molecular Medicine · doi:10.2174/156652413804486287 · Cited by 33
Self-citation
Prolyl Hydroxylase Inhibition During Hyperoxia Prevents Oxygen-Induced Retinopathy in the Rat 50/10 Model
Trichonas, G., Lee, T. J., Hoppe, G., Au, J. D., & Sears, J. E. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12171 · Cited by 31
Oxygen supplementation increases glucose tolerance during euglycaemic hyperinsulinaemic glucose clamp procedure in patients with severe COPD and chronic hypoxaemia
Jakobsson, P., & Jorfeldt, L. (2006) · Clinical Physiology and Functional Imaging · doi:10.1111/j.1475-097x.2006.00686.x · Cited by 30
Continuous Glucose Monitoring at High Altitude—Effects on Glucose Homeostasis
Hill, N. E., Deighton, K., Matu, J., Misra, S., Oliver, N. S., NEWMAN, C., Mellor, A. J., O'Hara, J. P., & Woods, D. R. (2018) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001624 · Cited by 28
Hypoxia‐inducible factor 1α (HIF‐1α) is a major determinant in the enhanced function of muscle‐derived progenitors from MRL/MpJ mice
Sinha, K. M., Tseng, C., Guo, P., Lu, A., Pan, H., Gao, X., Andrews, R., Eltzschig, H. K., & Huard, J. (2019) · The FASEB Journal · doi:10.1096/fj.201801794r · Cited by 28
β Cell Hypoxia-Inducible Factor-1α Is Required for the Prevention of Type 1 Diabetes
Lalwani, A., Warren, J. A., Liuwantara, D., Hawthorne, W. J., O’Connell, P. J., Gonzalez, F. J., Stokes, R., Chen, J. H., Laybutt, D. R., Craig, M. E., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.086 · Cited by 27
Self-citation
Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy
Ekberg, N. R., Eliasson, S., Li, Y. W., Zheng, X., Chatzidionysiou, K., Falhammar, H., Gu, H. F., & Catrina, S. (2019) · Journal of Diabetes Research · doi:10.1155/2019/2936962 · Cited by 26
Mortality trends and cause of death in patients with new-onset type 2 diabetes and controls: A 24-year follow-up prospective cohort study
Andersson, T., Hjerpe, P., Carlsson, A. C., Pivodic, A., Wändell, P. E., Manhem, K., & Boström, K. B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.01.038 · Cited by 24
Partial deficiency of HIF-1α stimulates pathological cardiac changes in streptozotocin-induced diabetic mice
Bohuslavová, R., Kolář, F., Sedmera, D., Skvorova, L., Papoušek, F., Neckář, J., & Pavlínková, G. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-11 · Cited by 23
A Biphasic Response of Rats to Cobalt
Roginski, E. E., & Mertz, W. (1977) · Journal of Nutrition · doi:10.1093/jn/107.8.1537 · Cited by 22
Hypoxia‐inducible factor 1 activation from adipose protein 2‐cre mediated knockout of von hippel‐lindau gene leads to embryonic lethality
Zhang, J., Wang, Y., Gao, Z., Yun, Z., & Ye, J. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05656.x · Cited by 20
Advances in cellular and integrative control of oxygen homeostasis within the central nervous system
Ramirez, J., Severs, L. J., Ramirez, S., & Agosto‐Marlin, I. M. (2018) · The Journal of Physiology · doi:10.1113/jp275890 · Cited by 20
The Veterans Affairs Continuous Positive Airway Pressure Use and Diabetic Retinopathy Study
Smith, J. P., Cyr, L. G., Dowd, L. K., Duchin, K. S., Lenihan, P. A., & Sprague, J. (2019) · Optometry and Vision Science · doi:10.1097/opx.0000000000001446 · Cited by 20
Glucose tolerance of lowlanders during prolonged stay at high altitude and among high altitude natives.
Kk, S., Kumria, M. M. L., Sk, G., Sridharan, K., & Ms, M. (1975) · PubMed · Cited by 20
Reduction of ARNT in myeloid cells causes immune suppression and delayed wound healing
Scott, C., Bonner, J. G., Min, D., Boughton, P. C., Stokes, R., Cha, K. M., Walters, S. N., Maslowski, K. M., Sierro, F., Grey, S. T., et al. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00306.2013 · Cited by 19
Self-citation
The Changing Landscape of Pharmacotherapy for Diabetes Mellitus: A Review of Cardiovascular Outcomes
Wu, L., & Gunton, J. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235853 · Cited by 19
Self-citation
Optimal cutoff values of fasting plasma glucose (FPG) variability for detecting retinopathy and the threshold of FPG levels for predicting the risk of retinopathy in type 2 diabetes: A longitudinal study over 27 years
Takao, T., Inoue, K., Suka, M., Yanagisawa, H., & Iwamoto, Y. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.051 · Cited by 17
HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury
Billin, A., Honeycutt, S. E., McDougal, A., Kerr, J. P., Chen, Z., Freudenberg, J., Rajpal, D., Luo, G., Kramer, H. F., Geske, R., et al. (2018) · Skeletal Muscle · doi:10.1186/s13395-018-0179-5 · Cited by 17
Connective tissue growth factor, matrix regulation, and diabetic kidney disease
McLennan, S. V., Abdollahi, M., & Twigg, S. M. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32835b4889 · Cited by 16
Role of prolyl hydroxylase domain proteins in the regulation of insulin secretion
Huang, M., Paglialunga, S., Wong, J. M.-K., Hoang, M., Pillai, R., & Joseph, J. W. (2016) · Physiological Reports · doi:10.14814/phy2.12722 · Cited by 14
Chiari Malformation Type 1 in EPAS1-Associated Syndrome
Rosenblum, J. S., Maggio, D. M., Pang, Y. K., Nazari, M. A., Gonzales, M. K., Lechan, R. M., Smirniotopoulos, J. G., Zhuang, Z., Pacák, K., & Heiss, J. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112819 · Cited by 14
Diabetes Medications and Cardiovascular Outcomes in Type 2 Diabetes
Chi, C., SNAITH, J. R., & Gunton, J. E. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.02.030 · Cited by 13
Self-citation
Age-dependent decline of hypothalamic HIF2α in response to insulin and its contribution to advanced age-associated metabolic disorders in mice
Wang, Z., Khor, S., & Cai, D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005429 · Cited by 13
Prolyl Hydroxylase Domain-2 Inhibition Improves Skeletal Muscle Regeneration in a Male Murine Model of Obesity
Sinha, I., Sakthivel, D., Olenchock, B. A., Kruse, C., Williams, J., Varon, D. E., Smith, J. D., Madenci, A. L., Nuutila, K., & Wagers, A. J. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00153 · Cited by 12
Diabetic pancreatic β cells ARNT all they should be
Levisetti, M. G., & Polonsky, K. S. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.07.005 · Cited by 11
Muscle Arnt/Hif1β Is Dispensable in Myofiber Type Determination, Vascularization and Insulin Sensitivity
Badin, P.-M., Sopariwala, D. H., Lorca, S., & Narkar, V. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168457 · Cited by 10
Overexpression of HIF-2α in pancreatic β cells does not alter glucose homeostasis
Brunt, J. J., Shi, S. Y., Schroer, S. A., Sivasubramaniyam, T., Cai, E. P., & Woo, M. (2014) · Islets · doi:10.1080/19382014.2015.1006075 · Cited by 8
Prolyl-hydroxylase 3 maintains [beta]-cell glucose-sensing under metabolic stress
Cuozzo, F., Nasteska, D., Thakker, A., Westbrook, R. L., Bakar, R. B., Cantley, J., Tennant, D. A., & Hodson, D. J. (2019) · Endocrine Abstracts · doi:10.1530/endoabs.65.oc1.5 · Cited by 1

Sorted by citations

Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
Lu, X., Xie, Q., Pan, X., Zhang, R., Zhang, X., Peng, G., Zhang, Y., Shen, S., & Tong, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01951-9 · Cited by 895
Hypoxia and hypoxia-inducible factors in diabetes and its complications
Catrina, S.-B., & Zheng, X. (2021) · Diabetologia · doi:10.1007/s00125-021-05380-z · Cited by 400
HIF-1α/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury
Zhao, M., Wang, S., Zuo, A., Zhang, J., Wen, W., Jiang, W., Chen, H., Liang, D., Sun, J. M., & Wang, M. (2021) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-021-00283-8 · Cited by 207
Hypoxia Promotes Breast Cancer Cell Growth by Activating a Glycogen Metabolic Program
Tang, K., Zhu, L., Chen, J., Wang, D., Zeng, L., Chen, C., Tang, L. V., Zhou, L., Wei, K., Zhou, Y., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0753 · Cited by 108
Inflammatory Trajectory of Type 2 Diabetes: Novel Opportunities for Early and Late Treatment
Pellegrini, V., Grotta, R. L., Carreras, F., Giuliani, A., Sabbatinelli, J., Olivieri, F., Berra, C., Ceriello, A., & Prattichizzo, F. (2024) · Cells · doi:10.3390/cells13191662 · Cited by 105

See all 167

Authors: Gunton, J. E.
Affiliations: The University of Sydney (AU)
Corresponding author: Gunton, Jenny E.
ORCID: Gunton, Jenny E.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2020-09-14
Volume: 130
Issue: 10
Pages: 5063-5073
ISSN: 0021-9738 (ISSN-L)
1558-8238
DOI: 10.1172/jci137556
PMC: PMC7524477
OpenAlex: W3071274483
Cited by: 159
References: 163
Citations by year: 2026: 22 · 2025: 24 · 2024: 25 · 2023: 40 · 2022: 33 · 2021: 15
FWCI: 2.40
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: NHMRC (AppID1149976)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords: hypoxia-inducible factor, HIF-1α, diabetes pathogenesis, hypoxia, hyperglycemia, beta-cell dysfunction, diabetes complications, microvascular complications, macrovascular complications, glycemic control
MeSH terms: Endothelial PAS Domain-Containing Protein 1, Animals, Diabetes Mellitus, Glucose, Humans, Models, Biological, Tissue Distribution, Diabetes Complications, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypoxia-inducible factors and diabetes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks